Cytosorbents (CTSO) Total Debt Growth (1y) (2012 - 2026)
Powered by 
Analysis
Cytosorbents (CTSO) Total Debt Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 142.67% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -1.59% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -9.88% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 8.95% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 0.12% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -9.07% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 12.29% |
| 10 | Cytosorbents | 20.00 Mn | 15.59 Mn | 7.05 Mn | 19.92% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.92% |
| Mar 31, 2026 | 19.54% |
| Dec 31, 2025 | 19.08% |
| Sep 30, 2025 | 5.51% |
| Jun 30, 2025 | 5.15% |
| Mar 31, 2025 | 220.35% |
| Dec 31, 2024 | 177.54% |
| Sep 30, 2024 | 135.38% |
| Jun 30, 2024 | 172.30% |
| Mar 31, 2024 | -11.62% |
| Dec 31, 2023 | 0.86% |
| Sep 30, 2020 | 34.09% |
| Jun 30, 2020 | 101.35% |
| Mar 31, 2020 | 65.54% |
| Dec 31, 2019 | 57.61% |
| Sep 30, 2019 | 82.92% |
| Jun 30, 2019 | 9.38% |
| Mar 31, 2019 | 17.85% |
| Dec 31, 2018 | -24.19% |
| Sep 30, 2018 | -23.51% |